Free Republic

COVID vaccines cause myocarditis, which is debilitating and deadly. The Israelis told Team Biden in February 2021. Team Biden kept a lid on that. So now we learn not only that Joe Biden has Stage Five prostate cancer, but that starting in February 2021, the POC/LGBTQ committee that was operating Biden like a Muppet concealed, then downplayed the risk of heart disease from the COVID vaccines. It’s funny how we find out all this dirt, within 48 hours after the committee’s announcement about Joe’s cancer. Because he’s got a few months to live, he’s now officially the “Fall Guy.” Everything...

Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, with a study demonstrating a 20% improvement in overall survival. However, lifestyle changes alone aren't enough for prevention. Fasting has been shown to activate autophagy, the body's natural process of cleaning out damaged cells and regenerating healthy ones. According to a review, autophagy plays a key role in preventing cancer development by maintaining cellular health and reducing oxidative stress. By clearing away cells that might otherwise turn cancerous, fasting may help the body maintain a more stable and resilient internal environment....

There’s a terrifying trend happening right now—and most of the so-called “experts” who have let us down in every way imaginable are pretending not to see it. So, what’s happening? Well, cancer is exploding. And not just in adults. Children—actually very young children—are now being diagnosed with these extremely aggressive, fast-moving cancers at a rate that’s impossible to ignore. But instead of asking hard questions, the same crowd of “experts” that once shouted down anyone who dared question the COVID vaccine has gone radio silent. Suddenly, they’ve lost all curiosity. Suddenly, they don’t want to “follow the science.” ... The...

Researchers have shown how a low-carbohydrate diet can worsen the DNA-damaging effects of some gut microbes to cause colorectal cancer. They found that a unique strain of E. coli bacteria, when paired with a diet low in carbs and soluble fiber, drives the growth of polyps in the colon, which can be a precursor to cancer. A low-carb diet paired with a strain of E. coli that produces the DNA-damaging compound colibactin—led to the development of colorectal cancer. The researchers found that a diet deficient in fiber increased inflammation in the gut and altered the community of microbes that typically...

Higher calcium intake is associated with reduced colorectal cancer (CRC) risk across tumor sites and calcium sources, according to a study. Semi Zouiouich, Ph.D., M.P.H. and colleagues examined the association between calcium intake and CRC risk in a cohort study analyzing data from the National Institutes of Health-AARP Diet and Health Study involving participants aged 50 to 71 years at baseline (October 1995 to May 1996) with self-reported good health and neither extremely high nor low caloric or calcium intake. The researchers identified 10,618 first primary CRC cases during 7,339,055 person-years of follow-up among 471,396 participants who were cancer-free at...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to the Phase III BREAKWATER trial. The findings demonstrated a 60.9% overall response rate (ORR) with the three-drug combination compared to 40% with the standard-of-care (SOC) treatment—chemotherapy with or without bevacizumab. In the experimental arm, 68.7% of patients had a duration of response of at least six months, compared to 34.1% of patients in the SOC arm. "This new regimen highlights the importance of combining dual-targeted therapy with chemotherapy." More than 150,000 people...

Modified Citrus Pectin has been studied now for more than 30 years, and there are some 50 published reports in the medical literature. While the most powerful evidence involves biochemically relapsed prostate cancer, it shows promise as a suppressor of metastases in a multitude of cancers including: Prostate cancer4 Breast cancer38 Colon cancer25 Melanoma4 Ovarian cancer4 Lung cancer4 Nasopharyngeal cancer4 Leukemias4 Glioblastomas4 Today I report the case of a 70-year-old farmer with Stage 4 colon cancer with liver metastases who became cancer-free following an MCP-based protocol. Andy Aubin was a robustly healthy farmer who had constructed his dream home in...

A team of epidemiologists has shown experimental evidence of an inverse relationship between incidences of Alzheimer's disease and colorectal cancer. The group found that mice with Alzheimer's-like symptoms were less likely than control colorectal mouse models to develop colorectal cancer. For years, doctors have been noticing that people who develop Alzheimer's are less likely to develop certain types of cancers, mostly particularly, colon cancer. They have also noticed the reverse; colorectal patients seem to be less likely to develop Alzheimer's disease. For this study, the researchers ran experiments with mice to find out whether an association exists. The researchers administered...

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study. For the study, researchers analyzed the health data from 107,655 participants from the Nurses' Health Study and Health Professionals Follow-Up Study. They compared the colorectal cancer rates in those who took aspirin regularly with those who did not take aspirin regularly. Regular aspirin use was defined as either two or more standard dose (325 mg) tablets per week or daily low-dose (81 mg) aspirin. Study participants were followed starting from an average age of 49.4 years. Those...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based biotechnology company Guardant Health, announced Monday that this is the first blood test to be approved by the FDA as a primary screening option for colorectal cancer, and it’s the first approved blood screening test for colorectal cancer that meets requirements for Medicare reimbursement. For patients with commercial insurance plans, the cost of the test may vary depending on their individual plan coverage. The list price for the...

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer disease-free survival compared to those without the mutation. After primary treatment for stage 3 colon cancer, patients typically receive adjuvant chemotherapy intended to reduce the risk of the cancer returning. In a subset of these patients, the cancer returns, and those patients have few treatment options. Researchers are looking for ways to improve adjuvant therapies and stave off recurrence. To investigate the use of...

A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two-thirds of patients, there were no longer any live tumor cells at the time of surgery. The patients' immune systems had cleaned up the cancer cells. These discoveries were made as part of the NICHE-2 trial. Patients with colon cancer with a specific genetic makeup, known as mismatch-repair deficient (dMMR) or microsatellite instable (MSI), were treated with one cycle of ipilimumab and...

With more and more people below the age of 50 being diagnosed with the illness, the medical community is urgently trying to determine a cause.The recent revelation by Kate Middleton, Princess of Wales, that she was battling cancer was a shock to many around the world. Middleton, who is only 42, has always appeared to be in the best of shape and in good health. Her diagnosis, however, only highlights the disturbing rise in the number of young people diagnosed with various forms of cancer, especially colon or colorectal cancer. Middleton is rumored to have been diagnosed with colorectal cancer,...

Around 29 million people in the US take a daily dose of aspirin as a preventative measure for cardiovascular disease. And while an age-related increased risk of bleeding has seen it fall out of favor with medical authorities, it's now shaping up as something that might be even more beneficial in triggering the immune system to help take down certain cancers. There's been a growing body of research showing that regular, long-term low-dose aspirin use was associated with better outcomes of colorectal cancer (CRC). But scientists haven't been entirely sure just why the common over-the-counter medicine was having a distinctive...

A type of bacteria that causes dental plaque may be behind a treatment-resistant form of colorectal cancer, a study published Wednesday in the journal Nature found. The particular bacterium, which appears to shield tumor cells from cancer-fighting drugs, was found in 50% of the tumors tested in the study. The discovery, experts say, could pave the way for new treatments and possibly new methods of screening. Colon cancer is the second-leading cause of cancer deaths in the United States and is expected to kill more than 53,000 people in the nation in 2024, according to the American Cancer Society. Rates...

The five people gathered around the restaurant table do not fit the profile of colon cancer patients. They’re female, and they’re young. Two were diagnosed in their 20s, one in her 30s, two in their early 40s. Their colon cancer support group gathers about once a month to share stories, such as the one about the doctor who said you just need a laxative, the one about the oncologist who said there’s nothing we can do for you but give you chemotherapy the rest of your life, the one about friends saying, “You don’t look sick,” without realizing that isn’t...

A study suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC). "Our results clearly demonstrate that GLP-1 RAs are significantly more effective than popular anti-diabetic drugs, such as Metformin or insulin, at preventing the development of CRC," said Nathan Berger. Glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, are medications to treat type 2 diabetes. Usually given by injection, they can lower blood-sugar levels, improve insulin sensitivity and help manage weight. They've also been shown to reduce the rates of major cardiovascular ailments. Importantly the protective effect of GLP-1 RAs...

Colorectal cancer (CRC) is expected to contribute to a burden of 3.2 million new cases and 1.6 million deaths by 2040. The authors open by discussing how microbes can be used to prevent CRC. Probiotics, when administered appropriately, enhance the intestinal barrier, modulate the hosts' immune response, remodel the gut microbial composition, and even induce targeted cancer cell death. The first-generation probiotics were formulations of lactic acid bacteria (LBA) from Lactobacillus, Lactococcus, Streptococcus, Enterococcus, Bacillus, Saccharomyces, and Bifidobacterium genera. On the other hand, next-generation probiotics (NGPs) incorporate microbes such as Bacteroides fragilis, Clostridium butyricum, Akkermansia muciniphila, and Faecalibacterium prausnitzii. Next,...

Researchers suggest that the intervention of probiotics is a potentially feasible strategy for preventing colon cancer. Colorectal cancer is the third most common cancer worldwide. Most patients are diagnosed at the middle and advanced stages due to the longer development of malignancies in the colon and rectum, as well as higher concealment compared to other cancers, which results in a narrow treatment window and high mortality rate. Gut microbiota and their secreted metabolites have a significant influence on the initiation and progression of colon cancer. The researchers at IMP have irradiated probiotic JY strain by heavy-ion beams, and obtained an...

Metabolites produced by gut bacteria during digestion can be used to trigger an immune response against colorectal cancer cells, according to new research that points toward a potential treatment for one of the deadliest forms of cancer. The research team found that the metabolites activate a molecule on the surface of the cancer cells that attracts immune cells, called T cells. The metabolites are also able to enter the nucleus of the cancer cells and alter their DNA, which further attracts the attention of the immune system. "What we saw is that these products regulate a key molecule on the...